Squamous cell carcinoma of the skin classification: Difference between revisions
No edit summary |
No edit summary |
||
Line 35: | Line 35: | ||
| style="background:#DCDCDC;" align="center" + |T4b | | style="background:#DCDCDC;" align="center" + |T4b | ||
| style="background:#F5F5F5;" align="left" + |Tumor with skull base invasion and/or skull base foramen involvement | | style="background:#F5F5F5;" align="left" + |Tumor with skull base invasion and/or skull base foramen involvement | ||
|- | |- | ||
| colspan="2" style="background:#A9A9A9;" align="left" + |N - Regional lymph nodes | | colspan="2" style="background:#A9A9A9;" align="left" + |N - Regional lymph nodes |
Revision as of 23:54, 10 June 2019
Squamous cell carcinoma of the skin Microchapters |
Differentiating Squamous cell carcinoma of the skin from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Squamous cell carcinoma of the skin classification On the Web |
American Roentgen Ray Society Images of Squamous cell carcinoma of the skin classification |
Squamous cell carcinoma of the skin classification in the news |
Directions to Hospitals Treating Squamous cell carcinoma of the skin |
Risk calculators and risk factors for Squamous cell carcinoma of the skin classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2], Raviteja Guddeti, M.B.B.S. [3]
Overview
Classification
Category | Criteria |
---|---|
T - Primary tumor | |
TX | Primary tumor cannot be assessed |
Tis | Carcinoma in situ |
T1 | Tumor ≤ to 2 cm |
T2 | Tumor > 2 cm, and ≤ to 4 cm |
T3 | Tumor > 4 cm or minor bone erosion or perineural invasion or deep invasion |
T4 | Tumor with gross cortical bone/marrow, skull base invasion and/or skull base foramen invasion |
T4a | Tumor with gross cortical bone/marrow invasion |
T4b | Tumor with skull base invasion and/or skull base foramen involvement |
N - Regional lymph nodes | |
NX | Regional lymph nodes cannot be assessed |
N0 | No regional lymph node metastasis |
N1 | Metastasis in a single ipsilateral lymph node, tumor size ≤ 3 cm, and no extranodal extension |
N2 | * Metastasis in a single ipsilateral lymph node, tumor size ≤ 3 cm, and presence of extranodal extension; or
|
N2a | Metastasis in a single ipsilateral lymph node 3 cm or smaller in greatest dimension and ENE(+); or
A single ipsilateral node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(–) |
N2b | Metastases in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension and ENE(–) |
N2c | Metastases in bilateral or contralateral lymph node(s), none larger than 6 cm in greatest dimension and ENE(–) |
N3 | Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(–); or
In a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or Multiple ipsilateral, contralateral, or bilateral nodes, any with ENE(+); or A single contralateral node of any size and ENE(+) |
N3a | Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(–) |
N3b | Metastasis in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or
Multiple ipsilateral, contralateral, or bilateral nodes, any with ENE(+); or A single contralateral node of any size and ENE(+) |
M - Distant metastasis | |
MX | Distant metastasis cannot be assessed |
M0 | No distant metastasis |
M1 | Distant metastasis |
M1a | Metastasis to one organ/site without peritoneal metastasis |
M1b | Metastasis to two or more organs/sites without peritoneal metastasis |
M1c | Metastasis to the peritoneal surface and/or metastasis to other organs/sites |